Regeneron Pharmaceuticals, Inc. (REGN) has 20 已知的内部人和机构持有人记录. 最大持有人为 YANCOPOULOS GEORGE 持有 310,460 股. 其他重要持有人包括 SCHLEIFER LEONARD S 和 VAGELOS P ROY.
过去12个月,内部人进行了 24 笔交易,涉及 REGN 股票 — 11 笔买入 (价值为 $6.06M) 和 4 笔卖出 (价值为 $1.25M). 内部人买入超过卖出,可能表明对公司前景有信心.
REGN 內部人持股
最大持股人
YANCOPOULOS GEORGE
310,460 股
主要內部人持股
| # |
姓名 |
职位 |
持股数量 |
最近申报日期 |
相对规模 |
| 1 |
Yancopoulos George |
Bd. Co-chair, President & CSO |
310,460 |
2026-01-05 |
|
| 2 |
Schleifer Leonard S |
Bd. Co-chair, President & CEO |
214,523 |
2026-01-05 |
|
| 3 |
Vagelos P Roy |
Director |
125,493 |
2023-04-05 |
|
| 4 |
Stahl Neil |
EVP Research and Development |
48,829 |
2024-12-18 |
|
| 5 |
Murphy Andrew J |
EVP Research |
47,833 |
2025-12-11 |
|
| 6 |
Larosa Joseph J |
EVP General Counsel and Secret |
30,075 |
2024-12-18 |
|
| 7 |
Van Plew Daniel P |
EVP & General Mgr, Industrial |
21,673 |
2025-12-11 |
|
| 8 |
Ryan Arthur F |
Director |
17,603 |
2026-04-03 |
|
| 9 |
Fenimore Christopher R. |
SVP Finance & CFO |
16,265 |
2024-12-18 |
|
| 10 |
Mccourt Marion |
EVP Commercial |
14,349 |
2025-12-11 |
|
| 11 |
Landry Robert E |
EVP Finance CFO |
11,787 |
2024-02-06 |
|
| 12 |
Poon Christine A |
Director |
1,962 |
2026-01-06 |
|
| 13 |
Sing George L |
Director |
1,962 |
2026-01-06 |
|
| 14 |
Goldstein Joseph L |
Director |
1,962 |
2026-01-06 |
|
| 15 |
Tessier-lavigne Marc |
Director |
1,929 |
2023-01-05 |
|
| 16 |
Coles N Anthony |
Director |
1,714 |
2026-01-06 |
|
| 17 |
Brown Michael S |
Director |
1,703 |
2026-01-06 |
|
| 18 |
Bassler Bonnie L |
Director |
1,703 |
2026-01-08 |
|
| 19 |
Pitofsky Jason |
SVP Controller |
905 |
2026-02-11 |
|
| 20 |
Zoghbi Huda Y |
Director |
800 |
2026-02-23 |
|
近期交易 (过去12个月)
| 日期 |
姓名 |
职位 |
类型 |
股数 |
股价 |
总价值 |
| 2026-04-01 |
Ryan Arthur F |
Director |
知情卖出 |
40 |
$779.71 |
$31.19K |
| 2026-03-02 |
Ryan Arthur F |
Director |
知情卖出 |
20 |
$789.28 |
$15.79K |
| 2026-02-19 |
Zoghbi Huda Y |
Director |
期权行权(卖出) |
1,638 |
$376.69 |
$617.02K |
| 2026-02-09 |
Pitofsky Jason |
SVP Controller |
期权行权(卖出) |
1,000 |
$492.00 |
$492K |
| 2026-02-09 |
Ryan Arthur F |
Director |
知情卖出 |
1 |
$787.82 |
$787.82 |
| 2026-01-07 |
Bassler Bonnie L |
Director |
知情卖出 |
1,500 |
$800.00 |
$1.2M |
| 2026-01-02 |
Guarini Kathryn |
Director |
限制性股票授予 (RSU) |
155 |
- |
- |
| 2026-01-02 |
Bassler Bonnie L |
Director |
限制性股票授予 (RSU) |
155 |
- |
- |
| 2026-01-02 |
Zoghbi Huda Y |
Director |
限制性股票授予 (RSU) |
155 |
- |
- |
| 2026-01-02 |
Schenkein David P |
Director |
限制性股票授予 (RSU) |
155 |
- |
- |
| 2026-01-02 |
Thompson Craig B. |
Director |
限制性股票授予 (RSU) |
155 |
- |
- |
| 2026-01-02 |
Goldstein Joseph L |
Director |
限制性股票授予 (RSU) |
1,962 |
$772.76 |
$1.52M |
| 2026-01-02 |
Sing George L |
Director |
限制性股票授予 (RSU) |
1,962 |
$772.76 |
$1.52M |
| 2026-01-02 |
Coles N Anthony |
Director |
限制性股票授予 (RSU) |
155 |
- |
- |
| 2026-01-02 |
Poon Christine A |
Director |
限制性股票授予 (RSU) |
1,962 |
$772.76 |
$1.52M |
| 2026-01-02 |
Ryan Arthur F |
Director |
限制性股票授予 (RSU) |
1,962 |
$772.76 |
$1.52M |
| 2026-01-02 |
Brown Michael S |
Director |
限制性股票授予 (RSU) |
155 |
- |
- |
| 2025-12-31 |
Yancopoulos George |
Bd. Co-chair, President & CSO |
RSU 预扣税 |
28,570 |
$772.09 |
$22.06M |
| 2025-12-31 |
Schleifer Leonard S |
Bd. Co-chair, President & CEO |
RSU 预扣税 |
28,570 |
$772.09 |
$22.06M |
| 2025-12-30 |
Sing George L |
Director |
期权行权(卖出) |
9,212 |
$520.01 |
$4.79M |
| 2025-12-09 |
Murphy Andrew J |
EVP Research |
RSU 预扣税 |
4,229 |
$701.51 |
$2.97M |
| 2025-12-09 |
Mccourt Marion |
EVP Commercial |
RSU 预扣税 |
1,021 |
$701.51 |
$716.24K |
| 2025-12-09 |
Van Plew Daniel P |
EVP & General Mgr, Industrial |
RSU 预扣税 |
2,552 |
$701.51 |
$1.79M |
| 2025-12-09 |
Yancopoulos George |
Bd. Co-chair, President & CSO |
RSU 预扣税 |
131,874 |
$701.51 |
$92.51M |